Wayne Keith Ward

Affiliations

  • Director at Skye Bioscience Inc. (SKYE), 2024-03-04
  • Chief Development Officer at Reata Pharmaceuticals Inc (RETA), 2019-02-27
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
RETA $91.62 8,367 $766,584.54 8,620 2019-02-26 Filing
RETA $91.00 16,817 $1,530,347.00 16,987 2019-02-26 Filing
RETA $91.00 15,183 $1,381,653.00 8,620 2019-02-25 Filing
RETA $76.97 2,750 $211,661.45 8,620 2019-01-31 Filing
RETA $76.17 1,400 $106,640.66 11,370 2019-01-31 Filing